BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND GNAS, RP4-543J19_4, 2778, ENSG00000087460, NESP55, NESP, GSP, POH, GNASXL, GNAS1, C20orf45, dJ309F20_1_1, SCG6, GPSA, Gnas, dJ806M20_3_3, XL2, MGC33735, XL, PHP1A, GSA, AHO, XLalphas, PHP1B AND Treatment
21509 results:

  • 1. Active surveillance is a feasible and safe strategy in selected patients with papillary thyroid cancer and suspicious cervical lymph nodes detected after thyroidectomy.
    Solórzano M; Lustig N; Mosso L; Espinoza M; Santana R; Gonzalez H; Montero PH; Cruz F; Solar A; Domínguez JM
    Arch Endocrinol Metab; 2024 May; 68():e230146. PubMed ID: 38709151
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The prophylactic antiemetic therapies in management of differentiated thyroid cancer patients with radioactive iodine therapy: a single-center, non-randomized clinical trial.
    Li X; Cao J; Wang W; Zhu X; Sun Y; Song L; Zhang W; Han Y
    Front Endocrinol (Lausanne); 2024; 15():1310223. PubMed ID: 38706697
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer: study protocol for cohort C of the open-label, phase 2, randomized controlled multicenter OPAL trial.
    Belotte J; Felicetti B; Baines AJ; YoussefAgha A; Rojas-Espaillat L; Ortiz AG; Provencher D; Vázquez RM; Cortijo LG; Zeng X
    Trials; 2024 May; 25(1):301. PubMed ID: 38702828
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The clinical value of iodine-125 seed implantation in the treatment of iodine-refractory differentiated thyroid carcinoma.
    Wan Q; Tan L; Tang X; Wang W; Su Y; Wu Z; Ke M; Chen Z
    Front Endocrinol (Lausanne); 2024; 15():1327766. PubMed ID: 38686207
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study.
    Pasternak B; Wintzell V; Hviid A; Eliasson B; Gudbjörnsdottir S; Jonasson C; Hveem K; Svanström H; Melbye M; Ueda P
    BMJ; 2024 Apr; 385():e078225. PubMed ID: 38683947
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Assessment of Thyroid Carcinogenic Risk and Safety Profile of GLP1-RA Semaglutide (Ozempic) Therapy for Diabetes Mellitus and Obesity: A Systematic Literature Review.
    Feier CVI; Vonica RC; Faur AM; Streinu DR; Muntean C
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673931
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Senolysis of gemcitabine-induced senescent human pancreatic cancer cells.
    Hoque MM; Iida Y; Kotani H; Harada M
    Cancer Rep (Hoboken); 2024 Apr; 7(4):e2075. PubMed ID: 38662379
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Exceptional lymph node recurrence of an unusual ovarian tumor 16 years later: a case report.
    Sakhri S; Slimane M; Bouaziz H; Khessairi N; Boujelbene N; Ben Dhiab T
    J Med Case Rep; 2024 Apr; 18(1):217. PubMed ID: 38654310
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Ultrasound and cytopathological characteristics of thyroid tumours of uncertain malignant potential - from diagnosis to treatment.
    Żyłka A; Dobruch-Sobczak K; Piotrzkowska-Wróblewska H; Jędrzejczyk M; Góralski P; Gałczyński J; Bakuła-Zalewska E; Dedecjus M
    Endokrynol Pol; 2024; 75(2):170-178. PubMed ID: 38646986
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Granulosa cell tumor of the ovary: a series of 6 cases.
    da Costa REAR; Silva MCA; Cavalcante ECX; Branco ROC; Dos Reis CA; Vieira SC
    Pan Afr Med J; 2024; 47():58. PubMed ID: 38646138
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prognostic value of combined psoas muscle mass and controlling nutritional status in patients with pancreatic ductal adenocarcinoma: a retrospective cohort study.
    Kuwabara S; Takeuchi Y; Sato O; Mizota T; Ichinokawa M; Murakawa K; Aoki Y; Ishido K; Ono K; Hirano S
    BMC Surg; 2024 Apr; 24(1):116. PubMed ID: 38643112
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Utilization of sperm cryopreservation in patients with testicular cancer.
    Menzel V; Richter E; Helke C; Bürk BT; Erb HHH; Leike S; Borkowetz A; Thomas C; Baunacke M
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):201. PubMed ID: 38630148
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Thyroid nodule rupture after radiofrequency ablation: case report and literature review.
    Ferraro T; Sajid S; Hodak SP; Baldwin CK
    Front Endocrinol (Lausanne); 2024; 15():1355383. PubMed ID: 38628591
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Defining distal splenopancreatectomy by the mesopancreas.
    Safi SA; Alexander A; Neuhuber W; Haeberle L; Rehders A; Luedde T; Esposito I; Fluegen G; Knoefel WT
    Langenbecks Arch Surg; 2024 Apr; 409(1):127. PubMed ID: 38625602
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A Study on the Retrospective Reinterpretation of BRCA1 and BRCA2 Variants.
    Kim JJ; Kim DJ; Nam EJ; Song KE; Ham JY; Kim YK; Lee NY
    Clin Lab; 2024 Apr; 70(4):. PubMed ID: 38623660
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Long-Term Follow-up of Patients With Autonomous Thyroid Nodules Treated With Radioiodine.
    Moroto D; Torquato-Vieira ICO; Fiorin LB; Camacho CP; Castiglioni MLV; Maciel RMB; Furlanetto RP; Matsumura LK; Janovsky CCPS; Lindsey SC; Martins JRM
    Clin Nucl Med; 2024 Jun; 49(6):529-535. PubMed ID: 38619976
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prevalence and Incidence of Fractures in Patients With Nonfunctional Adrenal Tumors.
    Lindh JD; Patrova J; Mannheimer B; Falhammar H
    JAMA Netw Open; 2024 Apr; 7(4):e246453. PubMed ID: 38619841
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A 14-year-old girl with premature ovarian insufficiency but with a positive pregnancy test.
    Touwslager RNH; Zwaan CM; Bakker B; Lentjes EGWM; Looijenga LHJ; van Santen HM
    J Pediatr Endocrinol Metab; 2024 May; 37(5):482-485. PubMed ID: 38618883
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Cytotoxic activity and cell specificity of a novel LHRH peptide drug conjugate, D-Cys6-LHRH vedotin, against ovarian cancer cell lines.
    Vankadara S; Ke Z; Wang S; Foo SY; Gunaratne J; Lee MA; Koh X; Chia CSB
    Chem Biol Drug Des; 2024 Apr; 103(4):e14516. PubMed ID: 38618710
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. treatment patterns and survival outcomes in patients with non-metastatic early-onset pancreatic cancer.
    Zhang LT; Zhang Y; Cao BY; Wu CC; Wang J
    World J Gastroenterol; 2024 Mar; 30(12):1739-1750. PubMed ID: 38617739
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 1076.